Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research
Top Cited Papers
Open Access
- 30 June 2010
- journal article
- research article
- Published by BMJ in Journal of Medical Genetics
- Vol. 47 (7), 436-444
- https://doi.org/10.1136/jmg.2009.074237
Abstract
25–30% of families fulfilling the criteria for hereditary diffuse gastric cancer have germline mutations of the CDH1 (E-cadherin) gene. In light of new data and advancement of technologies, a multidisciplinary workshop was convened to discuss genetic testing, surgery, endoscopy and pathology reporting. The updated recommendations include broadening of CDH1 testing criteria such that: histological confirmation of diffuse gastric criteria is only required for one family member; inclusion of individuals with diffuse gastric cancer before the age of 40 years without a family history; and inclusion of individuals and families with diagnoses of both diffuse gastric cancer (including one before the age of 50 years) and lobular breast cancer. Testing is considered appropriate from the age of consent following counselling and discussion with a multidisciplinary team. In addition to direct sequencing, large genomic rearrangements should be sought. Annual mammography and breast MRI from the age of 35 years is recommended for women due to the increased risk for lobular breast cancer. In mutation positive individuals prophylactic total gastrectomy at a centre of excellence should be strongly considered. Protocolised endoscopic surveillance in centres with endoscopists and pathologists experienced with these patients is recommended for: those opting not to have gastrectomy, those with mutations of undetermined significance, and in those families for whom no germline mutation is yet identified. The systematic histological study of prophylactic gastrectomies almost universally shows pre-invasive lesions including in situ signet ring carcinoma with pagetoid spread of signet ring cells. Expert histopathological confirmation of these early lesions is recommended.Keywords
This publication has 62 references indexed in Scilit:
- Quantification of Epigenetic and Genetic 2nd Hits in CDH1 During Hereditary Diffuse Gastric Cancer Syndrome ProgressionGastroenterology, 2009
- E-Cadherin Deficiency Initiates Gastric Signet-Ring Cell Carcinoma in Mice and ManCancer Research, 2009
- Germline CDH1 deletions in hereditary diffuse gastric cancer familiesHuman Molecular Genetics, 2009
- Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test resultsHuman Mutation, 2008
- Risk-reducing Total Gastrectomy for Germline Mutations in E-cadherin (CDH1): Pathologic Findings With Clinical ImplicationsThe American Journal of Surgical Pathology, 2008
- Hereditary diffuse gastric cancerCancer, 2008
- Founder and Recurrent CDH1 Mutations in Families With Hereditary Diffuse Gastric CancerJAMA, 2007
- CDH1 Truncating Mutations in the E-Cadherin GeneAnnals of Surgery, 2007
- Screening E-cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindredHuman Mutation, 2002
- Mutation and Cancer: Statistical Study of RetinoblastomaProceedings of the National Academy of Sciences of the United States of America, 1971